Skip to main content
. Author manuscript; available in PMC: 2017 Dec 1.
Published in final edited form as: Am J Ophthalmol. 2016 Sep 20;172:104–110. doi: 10.1016/j.ajo.2016.09.017

Figure 1.

Figure 1

Scleral photographs of patient 1. Scleral photographs of the inferior left eye were taken after administration of topical phenylephrine 10% at the indicated times in the study. Week 0 was the baseline image before gevokizumab treatment, week 16 was the primary end point after four monthly gevokizumab injections, and week 40 was four weeks following the last gevokizumab injection of the first extension phase.